Cannara Biotech Inc.

News & Events

Press Releases

In The Media

1. Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

   GlobeNewswire APR 28, 2025 7:00 AM EDT
   Record Revenue: Net revenues of $26.6 million in Q2 2025, a 35% increase compared to $19.7 mill...
   READ ARTICLE

2. Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

   GlobeNewswire APR 16, 2025 7:00 AM EDT
   MONTREAL, April 16, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara &...
   READ ARTICLE

3. Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors

   GlobeNewswire MAR 24, 2025 8:30 AM EDT
   MONTREAL, March 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara &...
   READ ARTICLE

4. Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025

   GlobeNewswire MAR 6, 2025 8:00 AM EST
   MONTREAL, March 06, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara &...
   READ ARTICLE

5. Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy

   GlobeNewswire FEB 24, 2025 8:00 AM EST
   MONTREAL, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ȁ...
   READ ARTICLE

6. Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025

   GlobeNewswire JAN 27, 2025 8:00 AM EST
   Record Revenue: Net revenues of $25.1 million in Q1 2025, a 29% increase compared to $19.5 ...
   READ ARTICLE

7. Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

   GlobeNewswire DEC 16, 2024 12:00 PM EST
   MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara &#...
   READ ARTICLE

8. Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

   GlobeNewswire DEC 12, 2024 9:30 AM EST
   MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara &#...
   READ ARTICLE

9. Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

   GlobeNewswire NOV 25, 2024 9:30 AM EST
   Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing ...
   READ ARTICLE

10. Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

    GlobeNewswire AUG 16, 2024 9:00 AM EDT
    MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (" Cannara " or the " ...
    READ ARTICLE